0001279569-19-000160.txt : 20190129 0001279569-19-000160.hdr.sgml : 20190129 20190129082244 ACCESSION NUMBER: 0001279569-19-000160 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20190129 FILED AS OF DATE: 20190129 DATE AS OF CHANGE: 20190129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neptune Wellness Solutions Inc. CENTRAL INDEX KEY: 0001401395 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33526 FILM NUMBER: 19547163 BUSINESS ADDRESS: STREET 1: 545 PROMENADE DU CENTROPOLIS STREET 2: SUITE 100 CITY: LAVAL STATE: A8 ZIP: H7T 0A3 BUSINESS PHONE: (450) 687-2262 MAIL ADDRESS: STREET 1: 545 PROMENADE DU CENTROPOLIS STREET 2: SUITE 100 CITY: LAVAL STATE: A8 ZIP: H7T 0A3 FORMER COMPANY: FORMER CONFORMED NAME: Neptune Technologies & Bioressources Inc. DATE OF NAME CHANGE: 20070530 6-K 1 neptune6k.htm 6-K

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 under

the Securities Exchange Act of 1934

 

For the month of: January 2019   Commission File Number: 001-33526

 

 

NEPTUNE WELLNESS SOLUTIONS INC.

(Translation of Registrant’s name into English)

 

 

545 Promende du Centropolis
Suite 100
Laval, Québec
Canada H7T 0A3
(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ¨            Form 40-F  x

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨             No  x

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A

 

 

 

 
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    NEPTUNE WELLNESS SOLUTIONS INC.
     
Date: January 29, 2019 By: /s/ Mario Paradis
  Name: Mario Paradis
  Title: VP & Chief Financial Officer

 

 

 

 

 

 

 

 
 

EXHIBIT INDEX

 

     
Exhibit   Description of Exhibit
99.1   Press Release dated January 29, 2019

 

 

 

 

 

 

 

 

 

 

EX-99.1 2 ex991.htm NEWS RELEASE DATED JANUARY 29, 2019

Exhibit 99.1

 

 

Logo: Neptune (CNW Group|Neptune Technologies & Bioresources inc.)

Neptune to Hold Conference Call to Discuss Third Quarter Results for the Three Months Period Ended December 31, 2018

LAVAL, QC, Jan. 29, 2019 /CNW Telbec/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), announces that it will be holding a conference call on February 13, 2019 at 5:00 PM (EST) to discuss its third quarter results for the three months period ended December 31, 2018.

The third quarter results press release will be issued on the same day after market close.

 

Conference Call Details:
   
Date: Wednesday, February 13, 2019
   
Time: 5:00 PM Eastern Standard Time
   
Call: 1-888-231-8191
   
Conference ID: 6499408
   
Webcast: A live webcast and presentation of the results can be accessed at:
https://neptunecorp.com/en/investors/events-and-presentations/

 

A replay of the call will be available for replay shortly after the call's completion, until March 13, 2019. The replay can be accessed online in the Investors section of Neptune's website under Investor Events and Presentations. It is also under this section that you will find the archive of the webcast, along with its accompanying presentation.

About Neptune Wellness Solutions Inc.

Neptune Wellness Solutions specializes in the extraction, purification and formulation of health and wellness products. Bringing decades of experience in the natural products sector to the legal cannabis industry, Neptune is licensed by Health Canada to process cannabis for the production of cannabis extracts and oils at its 50,000 square foot facility located in Sherbrooke, Quebec. Leveraging its scientific and technological expertise, Neptune acts as a service provider to license holders as part of a multi-phase growth strategy focused on the development of value-added and differentiated products for the Canadian and global cannabis markets. Neptune's activities also include the formulation, development and commercialization of turnkey nutrition solutions and patented ingredients such as MaxSimil®, and of a variety of marine and seed oils. Its head office is located in Laval, Quebec.

 

CisionView original content to download multimedia:http://www.prnewswire.com/news-releases/neptune-to-hold-conference-call-to-discuss-third-quarter-results-for-the-three-months-period-ended-december-31-2018-300785195.html

SOURCE Neptune Wellness Solutions Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2019/29/c9667.html

%CIK: 0001401395

For further information: Neptune Wellness Solutions, Mario Paradis, VP & CFO, Neptune, (450) 687-2262 x236, m.paradis@neptunecorp.com; Investor Relations Contact (Canada), Pierre Boucher, MaisonBrison, (514) 731-0000, pierre@maisonbrison.com; Investor Relations Contact (U.S.), Carolyn Capaccio / Jody Burfening, LHA, (212) 838-3777, ccapaccio@lhai.com / jburfening@lhai.com

CO: Neptune Wellness Solutions Inc.

CNW 07:30e 29-JAN-19

GRAPHIC 3 image_001.jpg GRAPHIC begin 644 image_001.jpg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end GRAPHIC 4 image_002.jpg GRAPHIC begin 644 image_002.jpg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end